EXPAREL® (bupivacaine liposome injectable suspension) is a local analgesic administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain.*

The ioverao system is a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves, interrupting the nerve’s ability to transmit a pain signal.

Proprietary multivesicular liposome (pMVL) technology encapsulates drugs, preserving their molecular structure, and releases them over a desired period of time.

ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) is the first and only approved treatment for osteoarthritis (OA) knee pain utilizing extended-release microsphere technology.

Pacira is expanding the clinical evidence for EXPAREL through trials across several surgical specialties. Please click here for a list of Pacira-sponsored trials that are currently ongoing.

*The clinical benefit of the decrease in opioid consumption was not demonstrated in the pivotal trials.